Appearing as a significant advance in the struggle against obesity, Retatrutide is capturing considerable buzz. It combines properties of two known GLP-1 binding agonists, liraglutide, with an additional glucose-dependent peptide component. Early patient results have demonstrated substantial fat reduction in people with a high BMI , possibly pr… Read More